What Medicare drug-cost changes are already confirmed for 2027?

Answered by 5 licensed agents

Several Medicare Part D changes are already confirmed for 2027:

- The maximum standard Part D deductible will increase from $615 to $700. Individual plans may charge a lower deductible or no deductible.

- The annual out-of-pocket limit for covered Part D medications will increase from $2,100 to $2,400. After reaching it, you pay $0 for covered Part D drugs for the rest of the year.

- Negotiated Medicare prices will begin for 15 additional medications, including Ozempic, Rybelsus, Wegovy, Trelegy Ellipta, Linzess and several cancer medications. Your personal savings will depend on your plan and how the drug is covered.

- The 2027 national base beneficiary premium will be $41.33, although this is not necessarily what an individual pays. Actual premiums vary by plan.

The insulin cost-sharing limit, $0 cost sharing for recommended Part D vaccines and the Medicare Prescription Payment Plan will continue.

Plan-specific premiums, formularies, pharmacy networks and copayments still need to be reviewed when 2027 plan information becomes available.

Answered by Lee Carroll on September 15, 2026

Agent Licensed in NC

Answered by Lee Carroll Medicare Insurance Agent

CMS's April 2026 final rule permanently codifies the IRA's Part D redesign into law: no coverage gap, $0 cost-sharing after the annual cap. For 2027, the standard deductible rises to $700 (from $615) and the out-of-pocket cap rises to $2,400 (from $2,100). Two other 2027 changes matter for your wallet: the Part D Premium Stabilization Demonstration expires, so stand-alone plan premiums lose their federal cushion and may shift more by plan; and a second batch of 15 negotiated drugs gets maximum fair prices. A separate program covers GLP-1 drugs (Wegovy, Zepbound KwikPen, and Foundayo) for eligible beneficiaries July 2026-Dec 2027 at a flat $50 copay, which doesn't count toward the deductible or cap. Actual plan costs vary and appear in your ANOC letter by Sept 30, ahead of AEP (Oct 15-Dec 7). As always, review your current prescriptions with a licensed, local Medicare agent.

Answered by Marc Gilman on September 15, 2026

Agent Licensed in NH, FL, KS & 11 other states

Answered by Marc Gilman Medicare Insurance Agent
CMS, Centers for Medicare & Medicaid Services, has set the 2027 Part D out-of-pocket maximum at $2,400 for covered Part D drugs, compared with $2,100 in 2026. The maximum standard Part D deductible rises from $615 to $700; some plans have lower or no deductibles.

Answered by Jeremy Harkins on September 14, 2026

Broker Licensed in TN, AR, CA & 5 other states

Answered by Jeremy Harkins Medicare Insurance Agent
Confirmed changes for 2027 Medicare prescription drug coverage include an increase in the maximum out-of-pocket spending limit to $2,400 (up from $2,100 in 2026) and a rise in the maximum annual deductible ceiling to $700 (up from $615).

The Centers for Medicare & Medicaid Services (CMS) and federal rules have finalized several major cost parameters taking effect on January 1, 2027

Answered by Christopher Horan on October 5, 2026

Agent Licensed in PA, DE, FL & NJ, NY, TX & VA

Answered by Christopher Horan Medicare Insurance Agent
For 2027, there is a little rise in the standard deductible for part D of $700 and the out of pocket spending cup rise of $2,400.

Answered by Mattie Macias on September 16, 2026

Agent Licensed in TN, MI, TX & VA

Answered by Mattie Macias Medicare Insurance Agent

Tags: Advice for Seniors Coverage The Medicare System

Agents: Share Your Expertise

Have insights or experiences related to this topic? Help others by sharing your knowledge and answering this question.

Seniors: Ask a Question of Your Own

Questions are generally answered within 1 to 3 business days. Receive valuable perspectives from multiple licensed agents and brokers.

Ask a Question